Suppr超能文献

委内瑞拉重型血友病 A 患者凝血因子 VIII 基因突变的鉴定:七种新突变的鉴定。

Identification of factor VIII gene mutations in patients with severe haemophilia A in Venezuela: identification of seven novel mutations.

机构信息

Laboratorio de Genética Molecular Humana B, Universidad Simón Bolívar, Caracas, Venezuela.

出版信息

Haemophilia. 2011 Sep;17(5):e913-8. doi: 10.1111/j.1365-2516.2011.02500.x. Epub 2011 Mar 4.

Abstract

Haemophilia A is caused by mutations in the gene encoding coagulation factor VIII (FVIII). In severe Haemophilia A (sHA), two inversions are responsible for approximately 50% of the genetic alterations (intron 22 and intron 1 inversions). The other mutations are extremely diverse and each affected family generally has its own mutation. Our aim was to detect the genetic alterations present in the FVIII gene (F8) in 54 unrelated male patients with sHA in Venezuela. We initially detected the presence of the intron 22 inversion by performing inverse PCR, and the negative patients for this inversion were analysed for the intron 1 inversion by PCR. Patients negative for both inversions were analysed using Conformation Sensitive Gel Electrophoresis for mutations in all exons, promoter region and 3'-UTR. sHA causative mutations were identified in 49 patients. Intron-22 and -1 inversions were detected in 41% and 0% of patients respectively. Besides these two mutations, 25 different mutations were identified, including nine nonsense, four small deletions, two small insertions, four missense, three splicing mutations and three large deletions. Seven novel mutations were identified, including two nonsense mutations, two small deletions, one small insertion, one missense mutation and one splicing mutation. Thirty one percent of the patients with identified mutations developed inhibitors against exogenous FVIII. This is the first report of F8 mutations in patients with sHA in Venezuela; the data from this study suggests that the spectrum of gene defects found in these patients is as heterogeneous as reported previously for other populations.

摘要

甲型血友病是由凝血因子 VIII(FVIII)基因的突变引起的。在严重甲型血友病(sHA)中,两个倒位约占 50%的遗传改变(内含子 22 和内含子 1 倒位)。其他突变极其多样化,每个受影响的家庭通常都有自己的突变。我们的目的是在委内瑞拉的 54 名患有 sHA 的男性患者中检测 FVIII 基因(F8)中存在的遗传改变。我们最初通过进行反向 PCR 来检测内含子 22 倒位的存在,对于这个倒位呈阴性的患者,我们通过 PCR 来分析内含子 1 倒位。对于两个倒位均呈阴性的患者,我们通过构象敏感凝胶电泳分析所有外显子、启动子区域和 3'-UTR 中的突变。在 49 名患者中鉴定出 sHA 致病突变。内含子-22 和 -1 倒位分别在 41%和 0%的患者中检测到。除了这两种突变,还鉴定出了 25 种不同的突变,包括 9 种无义突变、4 种小缺失、2 种小插入、4 种错义突变、3 种剪接突变和 3 种大片段缺失。鉴定出了 7 种新的突变,包括 2 种无义突变、2 种小缺失、1 种小插入、1 种错义突变和 1 种剪接突变。31%的有突变的患者产生了针对外源性 FVIII 的抑制剂。这是委内瑞拉首例 sHA 患者 F8 突变的报告;本研究的数据表明,这些患者的基因缺陷谱与之前报道的其他人群一样具有异质性。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验